JYNT
The Joint Corp.
Healthcare — Medical Care Facilities
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
None
3 analysts
$7.47
+$0.07 (+0.95%)
Target:
$10.00
(33.9%)
Price History
52-Week Range
Sign in to add JYNT to a watchlist or set price alerts.
Fundamentals
| Market Cap | $128.01M |
| P/E Ratio (TTM) | 99.78 |
| Forward P/E | 20.72 |
| EPS (TTM) | $0.09 |
| Dividend Yield | - |
| Profit Margin | 5.72% |
| Revenue Growth | 13.30% |
| ROE | 7.00% |
| Debt/Equity | 13.18 |
| Recommendation | None |
| Analyst Target | $10.00 |
| Analysts | 3 |
| Next Earnings | Aug 6, 2026 AMC |
| Indexes | - |
Technical Indicators
| RSI (14) | 56.9 |
| Beta | 1.10 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $12.27 |
| 52-Week Low | $7.50 |
| 50-Day Avg | $8.81 |
| 200-Day Avg | $8.87 |
| Avg Volume | 97.4K |
| Volume | 94.8K |
Performance Analysis
NEUTRALJYNT presents a mixed picture with both positive and negative indicators.
+
Trading near its 52-week low ($7.50), which could present a value opportunity.
+
RSI at 56.9 shows positive momentum.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
-
P/E of 99.8 is elevated — the market expects high growth or it may be overvalued.
~
Modest revenue growth of 13.3% year-over-year.
~
Wall Street consensus is "none" from 3 analysts.
+
Average analyst target of $10.00 implies 33.9% upside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:16 UTC
Back to Screener Export Report